West Tower Group, LLC Intra Cellular Therapies, Inc. Transaction History

West Tower Group, LLC

  • $46.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$46.37 - $73.65 $6,074 - $9,648
131 Added 137.89%
226 $16.2 Million
Q3 2023

Nov 14, 2023
SELL
$52.09 - $64.1 $10,313 - $12,691
-198 Reduced 67.58%
95 $4.95 Million
Q2 2023

Aug 14, 2023
BUY
$54.67 - $66.44 $16,018 - $19,466
293 New
293 $18.6 Million

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.87B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track West Tower Group, LLC Portfolio

Follow West Tower Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Tower Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Tower Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email